Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
5/2009 | Revascular Therapeutics | Series B | 3M |
10/2007 | APT Pharmaceuticals | Series A | 22M |
8/2001 | WhiteLight Systems | Venture Round | 7M |
8/2007 | KFx Medical | Series B | 10M |
6/2008 | CoMentis | Series D | 0 |
9/2006 | CoMentis | Series B | 50M |
10/2009 | Inviragen | Series A | 0 |
11/2009 | CymaBay Therapeutics | Series E | 0 |
6/2013 | Minimally invasive devices | Series B | 0 |
9/2014 | Prevacept Infection Control | Venture Round | 0 |
2/2008 | Corepair | Series B | 1.2M |
9/2005 | Kereos | Series B | 0 |
3/2013 | Minimally invasive devices | Series B | 9M |
8/2010 | Prevacept Infection Control | Series B | 3.1M |
12/2013 | Xlumena | Series C | 0 |
4/2011 | Xlumena | Series B | 0 |
4/2010 | Corepair | Series C | 4.5M |
5/2009 | Visioneering | Venture Round | 5M |
8/2007 | Mirabilis Medical | Series A | 10.5M |
8/2005 | KFx Medical | Series A | 6.2M |
10/2013 | Amaranth Medical | Series B | 0 |
9/2008 | APT Pharmaceuticals | Series B | 32M |
9/2006 | Amaranth Medical | Series A | 7.5M |
6/2006 | Bullhorn | Series C | 1.5M |
9/2014 | Prevacept Infection Control | Venture Round | 0 |
12/2013 | Xlumena | Series C | 0 |
10/2013 | Amaranth Medical | Series B | 0 |
6/2013 | Minimally invasive devices | Series B | 0 |
3/2013 | Minimally invasive devices | Series B | 0 |
4/2011 | Xlumena | Series B | 0 |
8/2010 | Prevacept Infection Control | Series B | 0 |
4/2010 | Corepair | Series C | 0 |
11/2009 | CymaBay Therapeutics | Series E | 0 |
10/2009 | Inviragen | Series A | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|